Search for: "Teva Pharmaceuticals USA Inc" Results 181 - 200 of 422
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 Jul 2018, 12:05 pm by Dennis Crouch
Teva Pharmaceuticals USA, Inc., et al., No. 17-1229. [read post]
8 Jun 2017, 3:27 am
Teva Pharmaceuticals USA, Inc., the Federal Circuit had its first opportunity to address the impact of the “or otherwise available to the public” clause contained in post-AIA 35 U.S.C. [read post]
13 Jun 2017, 12:00 pm by Daniel Taskalis
Teva Pharmaceuticals USA, Inc., the Federal Circuit had its first opportunity to address the impact of the “or otherwise available to the public” clause contained in post-AIA 35 U.S.C. [read post]
13 Jun 2017, 12:00 pm by Sheppard Mullin
Teva Pharmaceuticals USA, Inc., the Federal Circuit had its first opportunity to address the impact of the “or otherwise available to the public” clause contained in post-AIA 35 U.S.C. [read post]
25 Jun 2018, 7:03 am by Dennis Crouch
Teva Pharmaceuticals USA Inc., Docket No. 17-1229. [read post]
17 Oct 2014, 5:09 pm by Oyez Project
Stephens Teva Pharmaceuticals USA, Inc., v. [read post]
2 Nov 2020, 1:41 pm by Courtenay C. Brinckerhoff
Teva Pharmaceuticals USA, Inc., is getting attention for potentially “endangering” the practice of skinny labelling. [read post]
14 Apr 2014, 3:51 pm by Lyle Denniston
The generic firms — Sandoz Inc., Momenta Pharmaceuticals, Inc., Mylan Pharmaceuticals, Inc., and Natco Pharma Ltd. [read post]
23 Jul 2018, 2:38 pm by Jason Rantanen
Mylan Pharmaceuticals Inc., Teva Pharmaceuticals USA, Inc., AKORN, Inc. [read post]
26 Jan 2015, 11:54 am by Lyle Denniston
  The new dispute centers on the timing of lower-court actions that are to follow the Justices’ decision last Tuesday in Teva Pharmaceuticals USA, Inc., v. [read post]